Changes to Russian e-cigarette regulations questioned

Apr.18.2023
Changes to Russian e-cigarette regulations questioned
CRPT, the operator of the "honest label" system, confirms no changes to their system due to e-cigarette additives ban in Russia.

On April 17th, in response to the "ban on e-cigarette additives," 2FIRSTS Moscow News Center interviewed Yuri Babinkov, the manager of the tobacco department of the "Honest Label" operation company, about the potential impact of changes to related regulatory legislation on the existing "Honest Label" system.


Yuri Babinkov | Image Source: 2FIRSTS


According to Yuri Babinkov, the manager of the tobacco department at the CRPT, ...


There will be no changes to the "honest labeling" requirements, as electronic cigarettes will be subject to mandatory labeling restrictions.


However, he stated that due to the fact that ЦРПТ company is affiliated with the state, he is unable to answer any further questions regarding trade.


According to reports, CRPT Company is the fully authorized operator of the "Honest Label" system in Russia, and is a state-owned enterprise of the Russian Federation. On November 30, 2022, the revised version of the Russian Federation's Product Circulation Control Act No. 2178 will come into effect, which mandates the use of a tracking system for "tobacco and nicotine-containing products, as well as nicotine-free products." Failure to operate such products with traceability labels will result in penalties under the Russian Federation's Administrative Violations Code and Criminal Code, depending on the severity of the offense.


Honest Label" is a Russian product tracking system that currently covers more than a dozen categories, including tobacco, food, drugs, tires, and textiles. The system was launched in 2018 and has been effective in regulating product quality. On December 15th, 2022, e-cigarettes containing nicotine oil were included in the "Honest Label" regulation.


Related Reading:


Russian nicotine product producers must apply for a license" - This bill has passed its first reading.


In One Day, Russian Flavor Ban Timeline and Background Sketch Passes Three Readings Through Bill


Russian Ban on E-Cigarette Flavorings to Take Effect on September 1; Full Proposal Attached. On April 11, Russia Will Hold First Discussion on Proposal to Ban Flavored E-Cigarettes.


Russia proposes a maximum fine of 500,000 rubles for selling electronic cigarettes to minors.


What is the progress of the ban on certain flavors in Russia's legislative process? Here is an overview of the legislative process in Russia.


Interview with Russian producer of nicotine products: The trend towards regulatory compliance is irreversible, and a complete ban on e-cigarettes is unlikely.


Expert Analysis Series:


Expert interpretation 1: Russia's ban on flavored e-cigarettes extends to all products, and specific standards for additives are yet to be disclosed.


Expert Analysis 2: Russia Sets Minimum Retail Price for E-Cigarette Products to Reduce Demand for Nicotine-Based Products.


Expert interpretation 3: Russia proposes to ban the online sale and offline display of electronic cigarettes, effective June 1.


Topic: Progress and Expert Analysis on Russia's Ban on E-Cigarette Flavors (click the image below to go to the article)



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Recent reports from Germany and Switzerland show growing concern over vape and tobacco vending machines near schools or in public settings, with parents, teachers and residents questioning youth access, age-verification controls and the sale of vapes alongside snacks and drinks.
Jul.06
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
One year after the UK disposable vape ban came into force, local authorities continue to seize illegal and non-compliant vaping products. FOI data compiled by nicotine retailer Northerner shows more than 1.3 million products were seized between June 2025 and May 2026, with Bolton recording the highest number of seizures and Swansea reporting the highest estimated value.
Jul.21
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24